← Open Payments lookup

JENNIFER BECHER: Open Payments

NPI 1346540192 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,467 in 84 payments from 12 companies in 2025. Trend: 2023 $1,514 · 2024 $2,077 · 2025 $1,467

Food & beverage: $1,382Education: $85
CompanyPaymentsAmount
ABBVIE INC.20$354
Janssen Biotech, Inc.16$334
Madrigal Pharmaceuticals22$317
Takeda Pharmaceuticals U.S.A., Inc.9$140
Gilead Sciences, Inc.4$117
Amgen Inc.3$52
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$42
Regeneron Healthcare Solutions, Inc.2$39
Intercept Pharmaceuticals, Inc.2$29
IRONWOOD PHARMACEUTICALS, INC1$23

Products named: TREMFYA, REZDIFFRA, RINVOQ, LINZESS, ENTYVIO, SKYRIZI, UPLIZNA, XIFAXAN.

Industry payments across NE — which companies pay providers there.